Clinical trial / 2012
Turmeric supplementation decreased proteinuria, hematuria, and systolic blood pressure in lupus nephritis.
A randomized trial assigned 24 patients with relapsing or refractory lupus nephritis to take three daily capsules of either starch placebo or 500 mg turmeric (22.1 mg curcumin each) for 3 months. In the turmeric group, proteinuria fell from 954.2 ± 836.6 at baseline to 260.9 ± 106.2 at 3 months, alongside reductions in hematuria and systolic blood pressure. No changes occurred in the control group, and no adverse effects were observed.
- Study type
- Randomized controlled trial
- Who was studied
- 24 patients with relapsing or refractory lupus nephritis
- What was measured
- Proteinuria, hematuria, and systolic blood pressure
THE PAPER
Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study.
Khajehdehi P, Zanjaninejad B, Aflaki E, Nazarinia M, Azad F, Malekmakan L, Dehghanzadeh GR. J Ren Nutr, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.